Innovative Advisory Group, LLC’s Blueprint Medicines BPMC Stock Holding History

Innovative Advisory Group, LLC’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$128	–	256
2025 Q2	$128	Hold	1	–	–	﹤0.01%	242
2025 Q1	$89	Hold	1	–	–	﹤0.01%	231
2024 Q4	$87	Buy	+1	New	+$92	﹤0.01%	223

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Innovative Advisory Group, LLC's BPMC Position: Q3 2025 in Review

Innovative Advisory Group, LLC sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1 share — an estimated $128 sold.

Innovative Advisory Group, LLC first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $128 in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Innovative Advisory Group, LLC reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Innovative Advisory Group, LLC sold 1 Blueprint Medicines share in Q3 2025, an estimated $128.
Innovative Advisory Group, LLC first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
Innovative Advisory Group, LLC's Blueprint Medicines position peaked at $128 in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Innovative Advisory Group, LLC's 13F filing for Q3 2025, filed 23 Sep 2026.